Answers are grounded in this paper and cite their sources.
Case report highlights tocilizumab's effectiveness in treating refractory amyloid angiitis, indicating potential therapeutic strategies.
Describe the presentation of refractory amyloid β-related angiitis (ABRA) and response to cyclophosphamide and tocilizumab.
No takes yet. Share an insight, caveat, or question.
Byrne et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: